Determination of Indomethacin Crystallinity in the Presence of Excipients Using Diffuse Reflectance Near-Infrared Spectroscopy
- 1 January 2001
- journal article
- research article
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 6 (4) , 573-582
- https://doi.org/10.1081/pdt-120000295
Abstract
Studies were conducted to investigate the use of near-infrared spectroscopy for determining the crystallinity of indomethacin in multi-component physical mixtures. Three calibration sets of amorphous/crystalline indomethacin physical mixtures were prepared over the composition range of 0-100% crystallinity. Each of the three calibration sets was diluted step-wise with increasing amounts of a single excipient (Avicel, alpha-lactose monohydrate, or sodium chloride). Near-infrared spectra were obtained after each round of dilutions using diffuse reflectance sampling on samples contained in glass vials. After a second derivative transformation, standard curves were constructed by plotting percent indomethacin crystallinity against the ratio of responses at two wavelengths. At dilution levels up to 75% Avicel or lactose, the calibration models demonstrated high coefficients of determination and low standard errors. Dilution with sodium chloride did not produce comparable results and it was necessary to use partial least-squares regression to achieve a similar level of error. These findings were confirmed with separate validation sets. An investigation of instrument error showed that the impact of instrument variability on quantification generally increased as a function of the dilution level.Keywords
This publication has 10 references indexed in Scilit:
- Application of Diffuse Reflectance Near‐Infrared Spectroscopy for Determination of CrystallinityJournal of Pharmaceutical Sciences, 2000
- Quantitative analysis of polymorphs in binary and multi-component powder mixtures by near-infrared reflectance spectroscopyInternational Journal of Pharmaceutics, 2000
- Quantifying Crystalline Form Composition in Binary Powder Mixtures Using Near-Infrared Reflectance SpectroscopyPharmaceutical Development and Technology, 2000
- The Quantitative Analysis of Crystallinity Using FT-Raman SpectroscopyPharmaceutical Research, 1998
- Spectroscopic identification of an amorphous-to-crystalline drug transition in a solid dispersion SCH 48461 capsule formulationJournal of Pharmaceutical and Biomedical Analysis, 1997
- Spectroscopic Characterization of Interactions Between PVP and Indomethacin in Amorphous Molecular DispersionsPharmaceutical Research, 1997
- Characteristics and Significance of the Amorphous State in Pharmaceutical SystemsJournal of Pharmaceutical Sciences, 1997
- Quantification of crystallinity in blends of lyophilized and crystalline MK-0591 using x-ray powder diffractionInternational Journal of Pharmaceutics, 1995
- Quantitative effects of an absorbing matrix on near-infrared diffuse reflectance spectraAnalytical Chemistry, 1988
- Some physicochemical properties of glassy indomethacin.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986